Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04440982 · ClinicalTrials.gov registry record · Phase 2
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
A Phase 2 study, sponsored by Lumicell.
- Terminated
- Registry status
- Phase 2
- Development phase
- 98
- Enrollment target
NCT04440982 is a Phase 2 study that was terminated before completion, run by Lumicell. The registered enrollment target is 98 participants.
The verdict
NCT04440982, a Phase 2 study, was terminated before completion, sponsored by Lumicell.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 98 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, randomized, clinical trial evaluating patients undergoing breast conserving surgery using the LUM Imaging System.
Interventions
- DRUG LUM015
- DEVICE Lum Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2024-02-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04440982
The ClinicalTrials.gov registry entry for NCT04440982 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumicell, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LUM015 is the first listed.
NCT04440982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04440982 about?
NCT04440982 is a clinical study titled "Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients". This is a prospective, multi-center, randomized, clinical trial evaluating patients undergoing breast conserving surgery using the LUM Imaging System.
What is the current status of trial NCT04440982?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 98 participants. The study started on 2020-09-01. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT04440982?
The interventions under investigation include: LUM015 (DRUG), Lum Imaging System (DEVICE).
Who is sponsoring clinical trial NCT04440982?
This trial is sponsored by Lumicell, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.